You have 9 free searches left this month | for more free features.

Aliqopa

Showing 1 - 23 of 23

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Metastatic Castration-resistant Prostate Cancer Trial in San Francisco, Providence (Rucaparib, Copanlisib)

Active, not recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • San Francisco, California
  • +1 more
Nov 22, 2022

Chronic Lymphocytic Leukemia (CLL) Trial in Boston (Ibrutinib, Copanlisib, Acalabrutinib)

Recruiting
  • Chronic Lymphocytic Leukemia (CLL)
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
May 13, 2022

Diffuse Large B Cell Lymphoma, Relapsed DLBCL, Refractory DLBCL Trial in Boston (Copanlisib, Venetoclax)

Active, not recruiting
  • Diffuse Large B Cell Lymphoma
  • +2 more
  • Duarte, California
  • +2 more
Nov 10, 2022

Non Small Cell Lung Cancer Trial in Lexington (Durvalumab, Copanlisib)

Recruiting
  • Non Small Cell Lung Cancer
  • Lexington, Kentucky
    Markey Cancer Center
Feb 21, 2022

Recurrent Mantle Cell Lymphoma, Refractory Mantle Cell Lymphoma Trial in Duarte, New Haven (Copanlisib Hydrochloride,

Recruiting
  • Recurrent Mantle Cell Lymphoma
  • Refractory Mantle Cell Lymphoma
  • Duarte, California
  • +1 more
Aug 3, 2022

Lymphoma, Non-Hodgkin Trial in Beijing (Copanlisib (Aliqopa, BAY80-6946))

Completed
  • Lymphoma, Non-Hodgkin
  • Copanlisib (Aliqopa, BAY80-6946)
  • Beijing, China
    Beijing Cancer Hospital
May 17, 2021

Advanced Lymphoma, Advanced Malignant Solid Tumor, Hematopoietic and Lymphoid System Tumor Trial in Philadelphia (Biopsy,

Active, not recruiting
  • Advanced Lymphoma
  • +5 more
  • Biopsy
  • +3 more
  • Philadelphia, Pennsylvania
    ECOG-ACRIN Cancer Research Group
Aug 5, 2022

Hepatic Insufficiency, Renal Insufficiency Trial in Kiel, Bucuresti (Copanlisib (ALIQOPA, BAY80-6946))

Completed
  • Hepatic Insufficiency, Renal Insufficiency
  • Copanlisib (ALIQOPA, BAY80-6946)
  • Kiel, Schleswig-Holstein, Germany
  • +1 more
Apr 6, 2021

Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Refractory Malignant Solid Tumor Trial in Canada, United

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +2 more
  • Biopsy
  • +6 more
  • Boston, Massachusetts
  • +5 more
Jan 7, 2023

Platinum-Refractory Fallopian Tube Carcinoma, Platinum-Refractory Ovarian Carcinoma, Platinum-Refractory Primary Peritoneal

Recruiting
  • Platinum-Refractory Fallopian Tube Carcinoma
  • +11 more
  • Copanlisib Hydrochloride
  • +4 more
  • Aurora, Colorado
  • +2 more
Dec 8, 2022

Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Unresectable Malignant Solid Tumor Trial in United States

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +2 more
  • Biopsy
  • +7 more
  • Aurora, Colorado
  • +7 more
Nov 29, 2022

Anatomic Stage IV Breast Cancer AJCC v8, Hormone Receptor-Positive Breast Carcinoma, Metastatic Breast Carcinoma Trial in United

Recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +4 more
  • Birmingham, Alabama
  • +12 more
Nov 9, 2022

Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8

Suspended
  • Anatomic Stage III Breast Cancer AJCC v8
  • +12 more
  • Copanlisib Hydrochloride
  • Eribulin Mesylate
  • Gainesville, Florida
  • +10 more
Nov 16, 2022

Marginal Zone Lymphoma Trial in Austria, Germany (Copanlisib, Rituximab)

Recruiting
  • Marginal Zone Lymphoma
  • Wien, Austria
  • +19 more
Mar 14, 2022

Lymphoma, T-Cell Trial (Copanlisib, Romidepsin)

Withdrawn
  • Lymphoma, T-Cell
  • (no location specified)
Aug 11, 2020

Follicular Lymphoma Trial in Germany (Copanlisib, Obinutuzumab)

Recruiting
  • Follicular Lymphoma
  • München, Bavaria, Germany
  • +39 more
May 19, 2022

Healthy Volunteers Trial in Austin (Copanlisib (Aliqopa, BAY80-6946), Metformin)

Completed
  • Healthy Volunteers
  • Austin, Texas
    Pharmaceutical Product Development (PPD), LLC
Jan 14, 2020

Lymphoma, Non-Hodgkin Trial in Worldwide (Copanlisib (Aliqopa, BAY80-6946))

Active, not recruiting
  • Lymphoma, Non-Hodgkin
  • Copanlisib (Aliqopa, BAY80-6946)
  • Birmingham, Alabama
  • +100 more
Feb 10, 2022

Follicular Lymphoma, Non-Hodgkin's Lymphoma, NHL Trial run by the National Cancer Institute (NCI) (Rituximab, Copanlisib)

Recruiting
  • Follicular Lymphoma
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 25, 2023

Burkitt Lymphoma, High-grade B-cell Lymphoma, T-cell/Histocyte-rich Large B-cell Lymphoma Trial run by the NCI (Rituximab,

Suspended
  • Burkitt Lymphoma
  • +4 more
  • Rituximab
  • +6 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Diffuse, Large B-Cell, Lymphoma Trial in Worldwide (Copanlisib (Aliqopa, BAY80-6946))

Completed
  • Diffuse, Large B-Cell, Lymphoma
  • Copanlisib (Aliqopa, BAY80-6946)
  • Kingswood, New South Wales, Australia
  • +31 more
Dec 10, 2018

Tumors Trial in Scottsdale, Pittsburgh, San Antonio (Copanlisib (Aliqopa, BAY80-6946))

Completed
  • Neoplasms
  • Copanlisib (Aliqopa, BAY80-6946)
  • Scottsdale, Arizona
  • +2 more
Oct 5, 2017

Advanced Malignant Solid Tumor, Bladder Carcinoma, Breast Carcinoma Trial in Guam, Puerto Rico, United States (drug, procedure,

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +49 more
  • Birmingham, Alabama
  • +1429 more
Aug 17, 2022